Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany.
- DOI
- 10.3389/fimmu.2025.1576235
- Published
- 2025
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1576235,
title = {Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany.},
author = {Maurer M and Cimbollek S and Kelly M and Rodney K and Elliott J and LoboGuerrero E and Magerl M},
year = {2025},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2025.1576235},
url = {https://doi.org/10.3389/fimmu.2025.1576235}
}RIS
TY - JOUR TI - Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany. AU - Maurer M AU - Cimbollek S AU - Kelly M AU - Rodney K AU - Elliott J AU - LoboGuerrero E AU - Magerl M PY - 2025 JO - Frontiers in immunology DO - 10.3389/fimmu.2025.1576235 UR - https://doi.org/10.3389/fimmu.2025.1576235 ER -
APA
M, M., S, C., M, K., K, R., J, E., E, L., & M, M. (2025). Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1576235
Source records
- pubmed · retrieved 2026-09-26T20:49:30.235Z